publication date: Feb. 2, 2018
Trials and Tribulations
Re: Drug Pricing My unsolicited advice to HHS Secretary Alex Azar
By Patricia Goldsmith,
Chief Executive Officer of CancerCare
Dear Mr. Azar:
I am the leader of CancerCare, a national organization that provides free, professional support services to anyone affected by cancer. I’m writing this letter to offer some perspective regarding the plight of nearly 16 million U.S. cancer survivors, the many more who are family and care providers, and all of those who will be diagnosed in the coming years.
Cancer is a scourge that afflicts nearly 40 percent of Americans. If it doesn’t get you, it gets your spouse, sibling, parent or child. We all hope it doesn’t and if it does, we all hope for cure or control. And high quality of life. Fortunately, the pace of recent breakthroughs in effective cancer treatment is remarkable.
In fact, 2017 was the fourth consecutive year that personalized medicines accounted for more than 20 percent of FDA approvals. These treatments effectively and efficiently guide treatments to only those patients who will benefit from them, representing a revolution in how cancer is treated and a promise for a better future.
As you enter your new role, I ask that you keep in mind the landscape for cancer patients, who so often struggle to access and pay for high quality treatment. As patients, they want the … Continue reading Re: Drug Pricing My unsolicited advice to HHS Secretary Alex Azar
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.